The AP-2B (TFAP2B) transcription factor is overexpressed in LUAD and drives tumor growth via ERK and VEGF/PEDF signaling, associating with poor prognosis and plausibly regulating target motifs consistent with AP-2 binding [41]. Here, TFAP2B is linked to neoplasm.